GFRAL and Cachexia: However, the recent use of monoclonal antibodies inhibiting GFRAL signaling reversed the GDF15-induced cachexia even under calorie-restricted conditions, revealing that GDF15 may lead to decreased adipose and muscle mass and function independently of anorexia (31).